Spots Global Cancer Trial Database for Open Versus Laparoscopic Ablation of Liver Malignancies

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Open Versus Laparoscopic Ablation of Liver Malignancies

Official Title: Laparoscopic Versus Open Ablation of Liver Malignancies: a Randomized, Controlled Multicenter Trial

Study ID: NCT06304766

Conditions

Hepatocellular Carcinoma

Cholangiocarcinoma

Liver Metastases

Interventions

Laparoscopic ablation

Open ablation

Study Description

Brief Summary: The purpose of this study is to compare laparoscopic ablation to open ablation of liver malignancies regarding complication rates and ablation response as well as quality of life following the surgery.

Detailed Description: Liver malignancies is a major cause of cancer-related mortality and the incidence is increasing. Patients with liver malignancies are often left with limited surgical treatment options due to extensive tumor burden or comorbidities. Ablation is a less invasive treatment for these patients that can be performed percutaneously, by laparoscopy or open surgery. Ablation during open surgery has a high potential of complications. Laparoscopic ablation presumably has a lower complication rate than during open surgery, yet still offers some of the same advantages needed for tumors in locations not favorable for percutaneous ablation. This study aims to compare laparoscopic ablation with ablation during open surgery to investigate a treatment option with a supposed lower complication rate and equally treatment effectiveness after one month.